Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
68.97
Dollar change
+0.07
Percentage change
0.10
%
IndexRUT P/E- EPS (ttm)-0.13 Insider Own1.10% Shs Outstand50.77M Perf Week1.03%
Market Cap3.52B Forward P/E96.87 EPS next Y0.71 Insider Trans-16.90% Shs Float50.44M Perf Month0.74%
Income-6.09M PEG- EPS next Q-0.05 Inst Own100.91% Short Float5.84% Perf Quarter9.60%
Sales366.38M P/S9.60 EPS this Y399.12% Inst Trans3.14% Short Ratio2.21 Perf Half Y23.51%
Book/sh12.56 P/B5.49 EPS next Y98.36% ROA-0.88% Short Interest2.94M Perf Year25.67%
Cash/sh6.76 P/C10.20 EPS next 5Y- ROE-1.01% 52W Range47.59 - 69.68 Perf YTD10.83%
Dividend Est.- P/FCF- EPS past 5Y36.15% ROI-0.92% 52W High-1.02% Beta0.56
Dividend TTM- Quick Ratio8.98 Sales past 5Y541.82% Gross Margin72.46% 52W Low44.93% ATR (14)0.49
Dividend Ex-Date- Current Ratio10.73 EPS Y/Y TTM90.17% Oper. Margin-1.29% RSI (14)64.70 Volatility0.48% 0.75%
Employees797 Debt/Eq0.04 Sales Y/Y TTM33.86% Profit Margin-1.66% Recom2.85 Target Price71.40
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q908.33% Payout- Rel Volume0.52 Prev Close68.90
Sales Surprise2.24% EPS Surprise101.55% Sales Q/Q27.72% EarningsFeb 28 AMC Avg Volume1.33M Price68.97
SMA201.37% SMA501.37% SMA20016.67% Trades Volume698,660 Change0.10%
Date Action Analyst Rating Change Price Target Change
Jan-09-24Downgrade Wolfe Research Outperform → Peer Perform
Jul-19-23Initiated Robert W. Baird Outperform $69
Jul-13-23Initiated KeyBanc Capital Markets Overweight $70
May-23-23Initiated CL King Buy $75
Apr-14-23Initiated Mizuho Buy $75
Mar-24-23Upgrade Needham Hold → Buy $71
Oct-21-22Initiated RBC Capital Mkts Outperform $85
Oct-12-22Initiated Jefferies Hold $75
Oct-10-22Downgrade Needham Buy → Hold
Apr-06-22Initiated Wolfe Research Outperform $69
Mar-22-24 04:01PM
Mar-21-24 04:54PM
Mar-15-24 08:53AM
Mar-14-24 06:00AM
Feb-29-24 04:01PM
07:01PM Loading…
Feb-28-24 07:01PM
05:40PM
04:41PM
04:01PM
Feb-02-24 09:09PM
Jan-31-24 06:30AM
Jan-29-24 11:02PM
Jan-25-24 08:07AM
Jan-23-24 02:45PM
Jan-10-24 03:07PM
07:38PM Loading…
Jan-08-24 07:38PM
11:28AM
07:58AM
07:00AM
07:00AM
07:00AM
Dec-27-23 04:01PM
Nov-20-23 09:55AM
Nov-06-23 12:00PM
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM
04:28PM
04:01PM
10:02AM Loading…
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Aug-17-22 06:00AM
Aug-08-22 12:00PM
Aug-05-22 04:34PM
Aug-04-22 09:40AM
Aug-02-22 11:13PM
04:11PM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Noblett KarenChief Medical OfficerJan 31 '24Option Exercise0.0027,500045,716Feb 02 05:59 PM
Sama RindaChief Operating OfficerJan 31 '24Option Exercise0.0028,000083,854Feb 02 06:00 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31 '24Option Exercise0.0028,000093,302Feb 02 05:59 PM
Ford Alfred J JrChief Commercial OfficerJan 31 '24Option Exercise0.0025,500060,065Feb 02 05:59 PM
COHEN RAYMOND WChief Executive OfficerJan 31 '24Option Exercise0.0063,4000223,996Feb 02 05:59 PM
Keese Kari LeighChief Financial OfficerJan 31 '24Option Exercise0.006,167046,812Feb 02 05:59 PM
COHEN RAYMOND WChief Executive OfficerJan 31 '24Sale67.7435,1612,381,662188,835Feb 02 05:59 PM
Ford Alfred J JrChief Commercial OfficerJan 31 '24Sale67.7416,6151,125,43243,450Feb 02 05:59 PM
Woock JohnEVP, Chief Mktg/Strtgy OfficerJan 31 '24Sale67.7415,8991,076,93377,403Feb 02 05:59 PM
Noblett KarenChief Medical OfficerJan 31 '24Sale67.7411,288764,60334,428Feb 02 05:59 PM
Keese Kari LeighChief Financial OfficerJan 31 '24Sale67.743,489236,33143,323Feb 02 05:59 PM
Noblett KarenChief Medical OfficerJan 08 '24Sale69.0015,9991,103,96118,216Jan 10 08:00 PM
Noblett KarenChief Medical OfficerDec 28 '23Sale63.287,051446,17734,215Dec 28 07:17 PM
Noblett KarenChief Medical OfficerDec 26 '23Sale63.0094959,78741,266Dec 28 07:17 PM
Dearen Danny L.President & CFOSep 29 '23Option Exercise0.0011,250031,452Oct 03 07:37 PM
Dearen Danny L.President & CFOSep 29 '23Sale56.877,675436,49023,777Oct 03 07:37 PM
Ford Alfred J JrChief Commercial OfficerAug 15 '23Sale62.3414,769920,67134,565Aug 17 07:47 PM
Ford Alfred J JrChief Commercial OfficerJul 28 '23Sale62.011,50093,02149,334Aug 01 08:01 PM
Dearen Danny L.President & CFOMay 26 '23Sale49.467,999395,6469,202May 31 08:01 PM
Dearen Danny L.President & CFOApr 21 '23Option Exercise14.1913,208187,42237,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 21 '23Sale60.2120,0001,204,13717,201Apr 25 08:06 PM
Dearen Danny L.President & CFOApr 20 '23Option Exercise14.192,00128,39425,994Apr 24 08:35 PM
Dearen Danny L.President & CFOApr 20 '23Sale60.012,001120,07323,993Apr 24 08:35 PM
Dearen Danny L.President & CFOMar 31 '23Option Exercise16.0015,000240,03138,993Apr 04 08:24 PM
Dearen Danny L.President & CFOMar 31 '23Sale55.2715,000829,10323,993Apr 04 08:24 PM
Last Close
Mar 28 04:00PM ET
18.55
Dollar change
+0.09
Percentage change
0.49
%
BLFS Biolife Solutions Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.52 Insider Own4.62% Shs Outstand45.17M Perf Week1.59%
Market Cap840.31M Forward P/E- EPS next Y-0.60 Insider Trans59.31% Shs Float43.21M Perf Month8.48%
Income-66.43M PEG- EPS next Q-0.34 Inst Own100.68% Short Float7.02% Perf Quarter10.02%
Sales143.27M P/S5.87 EPS this Y33.82% Inst Trans5.04% Short Ratio7.36 Perf Half Y32.03%
Book/sh7.48 P/B2.48 EPS next Y40.36% ROA-15.40% Short Interest3.03M Perf Year-9.91%
Cash/sh1.14 P/C16.24 EPS next 5Y10.00% ROE-18.93% 52W Range8.92 - 24.50 Perf YTD14.15%
Dividend Est.- P/FCF- EPS past 5Y0.51% ROI-17.94% 52W High-24.29% Beta1.67
Dividend TTM- Quick Ratio1.83 Sales past 5Y57.29% Gross Margin29.02% 52W Low107.96% ATR (14)0.90
Dividend Ex-Date- Current Ratio2.86 EPS Y/Y TTM53.47% Oper. Margin-40.16% RSI (14)57.95 Volatility4.08% 6.28%
Employees414 Debt/Eq0.13 Sales Y/Y TTM-11.43% Profit Margin-46.37% Recom1.29 Target Price23.00
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q74.02% Payout- Rel Volume1.26 Prev Close18.46
Sales Surprise-2.00% EPS Surprise12.20% Sales Q/Q-26.04% EarningsFeb 29 AMC Avg Volume412.28K Price18.55
SMA205.16% SMA505.16% SMA20017.05% Trades Volume519,488 Change0.49%
Date Action Analyst Rating Change Price Target Change
Jul-11-23Initiated Craig Hallum Buy $29
Apr-25-22Upgrade Oppenheimer Perform → Outperform $28
Oct-19-21Initiated B. Riley Securities Buy $61
Oct-15-21Resumed Cowen Outperform $64
May-14-21Downgrade The Benchmark Company Buy → Hold
Mar-23-21Upgrade The Benchmark Company Hold → Buy $54
Nov-10-20Initiated KeyBanc Capital Markets Overweight $40
Sep-22-20Downgrade Oppenheimer Outperform → Perform
Sep-18-20Initiated Cowen Outperform $33
Aug-11-20Downgrade The Benchmark Company Buy → Hold
Mar-27-24 04:37PM
Mar-14-24 02:15AM
Mar-13-24 01:50AM
Mar-04-24 08:03AM
Mar-02-24 08:16AM
06:02AM Loading…
Mar-01-24 06:02AM
Feb-29-24 04:03PM
Feb-20-24 08:03AM
Jan-08-24 08:15AM
Nov-16-23 02:54AM
Nov-10-23 02:33PM
Nov-09-23 04:04PM
Nov-02-23 04:03PM
12:27AM
Oct-19-23 05:04PM
04:24AM Loading…
Oct-09-23 04:24AM
Sep-13-23 07:47AM
Aug-11-23 04:06PM
06:05AM
Aug-09-23 01:38PM
Aug-08-23 06:30PM
04:03PM
Jul-27-23 04:03PM
Jul-26-23 01:30PM
Jun-21-23 08:00PM
Jun-14-23 08:03AM
Jun-06-23 08:03AM
May-12-23 07:45AM
May-11-23 07:34AM
May-10-23 05:35PM
04:03PM Loading…
04:03PM
May-02-23 04:03PM
Apr-26-23 08:00PM
Mar-20-23 10:46PM
Mar-17-23 08:39AM
Mar-16-23 04:03PM
Mar-13-23 09:40AM
Mar-10-23 03:38PM
Mar-09-23 04:03PM
Mar-01-23 08:03AM
Feb-17-23 09:40AM
Jan-26-23 08:00AM
Jan-17-23 08:04AM
Jan-10-23 08:05AM
Jan-09-23 08:05AM
Jan-06-23 07:31AM
Jan-03-23 06:26AM
Dec-19-22 08:03AM
Dec-18-22 04:43PM
Dec-10-22 07:12AM
Nov-21-22 08:05AM
Nov-17-22 08:05AM
Nov-11-22 05:27AM
Nov-09-22 06:05PM
04:05PM
Nov-03-22 08:52AM
Oct-11-22 10:10AM
Oct-03-22 08:03AM
Aug-25-22 08:03AM
Aug-09-22 06:35PM
04:07PM
Aug-02-22 04:05PM
Jul-18-22 06:20AM
Jun-09-22 08:05AM
Jun-02-22 12:34PM
May-09-22 05:45PM
04:03PM
May-05-22 05:15PM
May-02-22 07:28PM
07:47AM
Apr-26-22 11:18AM
Apr-07-22 04:45PM
Mar-31-22 06:44AM
Mar-18-22 05:43PM
Mar-17-22 08:05AM
Mar-15-22 08:05AM
Mar-01-22 08:05AM
Feb-28-22 06:15PM
04:03PM
Feb-21-22 08:03AM
Feb-11-22 11:40AM
Feb-02-22 05:16AM
Feb-01-22 05:38PM
Jan-27-22 05:38PM
Jan-10-22 08:00AM
Jan-04-22 08:06AM
Dec-16-21 10:15AM
08:03AM
Dec-10-21 10:15AM
Dec-09-21 09:15AM
Nov-19-21 11:50AM
Nov-18-21 10:31AM
Nov-17-21 01:08PM
Nov-15-21 08:05AM
Nov-11-21 07:30PM
04:05PM
Nov-05-21 11:52AM
Nov-04-21 04:05PM
08:03AM
07:34AM
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wichterman TroyChief Financial OfficerMar 21 '24Sale17.835209,272127,614Mar 25 05:03 PM
DuRoss AmyDirectorMar 13 '24Sale17.005,06586,10529,443Mar 13 06:37 PM
Wichterman TroyChief Financial OfficerMar 12 '24Sale16.607,249120,333128,134Mar 12 09:43 PM
DE GREEF RODERICKPresident and CEOMar 12 '24Sale16.607,249120,333461,854Mar 12 09:43 PM
Berard ToddChief Marketing OfficerMar 12 '24Sale16.607,107117,976140,159Mar 12 09:44 PM
Mathew Aby J.EVP & Chief Scientific OfficerMar 12 '24Sale16.606,521108,249320,136Mar 12 09:44 PM
DuRoss AmyDirectorMar 12 '24Sale16.866,135103,43634,508Mar 13 06:37 PM
Foster Karen A.Chief Quality and OperationsMar 12 '24Sale16.605,17785,938159,540Mar 12 09:43 PM
Aebersold SarahChief Human Resources OfficerMar 12 '24Sale16.604,36172,39369,843Mar 12 09:42 PM
Phillips GeraintSVP, Global OperationsMar 12 '24Sale16.603,59859,72765,998Mar 12 09:44 PM
Berard ToddChief Marketing OfficerMar 11 '24Sale17.424016,985147,266Mar 12 09:44 PM
Wichterman TroyChief Financial OfficerMar 11 '24Sale17.423616,289135,383Mar 12 09:43 PM
Foster Karen A.Chief Quality and OperationsMar 11 '24Sale17.423195,557164,717Mar 12 09:43 PM
Mathew Aby J.EVP & Chief Scientific OfficerMar 11 '24Sale17.423135,452326,657Mar 12 09:44 PM
Aebersold SarahChief Human Resources OfficerMar 11 '24Sale17.422694,68674,204Mar 12 09:42 PM
Phillips GeraintSVP, Global OperationsMar 11 '24Sale17.422063,58969,596Mar 12 09:44 PM
Phillips GeraintSVP, Global OperationsFeb 21 '24Sale17.351312,27358,120Feb 23 05:51 PM
Berard ToddChief Marketing OfficerFeb 21 '24Sale17.351111,926115,688Feb 23 05:51 PM
Mathew Aby J.EVP & Chief Scientific OfficerFeb 21 '24Sale17.351011,752275,214Feb 23 05:51 PM
Wichterman TroyChief Financial OfficerFeb 21 '24Sale17.35971,68364,823Feb 23 05:51 PM
Foster Karen A.Chief Quality and OperationsFeb 21 '24Sale17.35871,509123,940Feb 23 05:50 PM
Aebersold SarahChief Human Resources OfficerFeb 21 '24Sale17.35581,00641,806Feb 23 05:52 PM
Aebersold SarahChief Human Resources OfficerJan 23 '24Sale17.113365,74941,864Jan 25 05:10 PM
DE GREEF RODERICKPresident and CEOJan 19 '24Sale16.762,64244,280439,897Jan 23 05:29 PM
Wichterman TroyChief Financial OfficerJan 19 '24Sale16.762,41940,54264,920Jan 23 05:29 PM
Phillips GeraintSVP, Global OperationsJan 19 '24Sale16.761,77629,76658,251Jan 23 05:30 PM
Mathew Aby J.EVP & Chief Scientific OfficerJan 19 '24Sale16.761,45024,302275,315Jan 23 05:30 PM
Berard ToddChief Marketing OfficerJan 19 '24Sale16.761,23220,648115,799Jan 23 05:29 PM
Foster Karen A.Chief Quality and OperationsJan 19 '24Sale16.761,19820,078124,027Jan 23 05:30 PM
Aebersold SarahChief Human Resources OfficerJan 19 '24Sale16.7686214,44742,200Jan 23 05:29 PM
Mathew Aby J.EVP & Chief Scientific OfficerJan 02 '24Sale16.7569711,675276,765Jan 04 05:03 PM
Foster Karen A.Chief Quality and OperationsJan 02 '24Sale16.7560110,067125,225Jan 04 05:04 PM
Berard ToddChief Marketing OfficerJan 02 '24Sale16.754918,224117,031Jan 04 05:04 PM
Wichterman TroyChief Financial OfficerDec 22 '23Sale16.793145,27267,339Dec 28 04:46 PM
Wichterman TroyChief Financial OfficerDec 01 '23Sale12.376668,23867,112Dec 04 07:14 PM
Mathew Aby J.EVP & Chief Scientific OfficerDec 01 '23Sale12.375917,311275,961Dec 04 07:15 PM
Foster Karen A.Chief Quality OfficerDec 01 '23Sale12.374665,764125,340Dec 04 07:15 PM
Berard ToddChief Marketing OfficerDec 01 '23Sale12.373944,874117,522Dec 04 07:14 PM
Aebersold SarahChief Human Resources OfficerDec 01 '23Sale12.373944,87443,062Dec 04 07:15 PM
Phillips GeraintSVP, Global OperationsDec 01 '23Sale12.373033,74859,587Dec 04 07:14 PM
Mathew Aby J.EVP & Chief Scientific OfficerNov 13 '23Sale10.771321,422275,726Nov 15 10:41 AM
Foster Karen A.Chief Quality OfficerNov 13 '23Sale10.771141,228125,539Nov 15 10:41 AM
Phillips GeraintSVP, Global OperationsNov 13 '23Sale10.661111,18359,656Nov 15 10:41 AM
Berard ToddChief Marketing OfficerNov 13 '23Sale10.77981,055117,916Nov 15 10:41 AM
Wichterman TroyChief Financial OfficerNov 13 '23Sale10.66971,03467,480Nov 15 10:40 AM
Aebersold SarahChief Human Resources OfficerNov 13 '23Sale10.777681943,456Nov 15 10:41 AM
Rice MichaelFormer CEO and DirectorOct 30 '23Sale9.1372,603662,865347,085Nov 01 05:30 PM
Casdin Partners Master Fund, L10% OwnerOct 19 '23Buy11.19927,16510,374,9768,557,165Oct 23 05:42 PM
Rice MichaelChief Executive OfficerSep 28 '23Sale14.1683111,767418,635Oct 02 05:07 PM
Mathew Aby J.EVP & Chief Scientific OfficerSep 28 '23Sale14.166599,331273,121Oct 02 05:04 PM
Foster Karen A.Chief Quality OfficerSep 28 '23Sale14.165688,043124,767Oct 02 05:08 PM
Berard ToddChief Marketing OfficerSep 28 '23Sale14.164646,570118,014Oct 02 04:56 PM
Wichterman TroyChief Financial OfficerSep 21 '23Sale12.705396,84566,300Sep 25 04:57 PM
Rice MichaelChief Executive OfficerAug 25 '23Sale10.991,72919,002416,906Aug 29 05:53 PM
Wichterman TroyChief Financial OfficerAug 25 '23Sale10.995856,42965,933Aug 29 05:51 PM
Mathew Aby J.EVP & Chief Scientific OfficerAug 25 '23Sale10.995195,704271,220Aug 29 05:53 PM
Foster Karen A.Chief Quality OfficerAug 25 '23Sale10.994104,506124,342Aug 29 05:52 PM
Aebersold SarahChief Human Resources OfficerAug 25 '23Sale10.993473,81443,532Aug 29 05:48 PM
Schulz MarcusChief Revenue OfficerAug 25 '23Sale10.993473,81442,097Aug 29 05:54 PM
Berard ToddChief Marketing OfficerAug 25 '23Sale10.993473,814118,478Aug 29 05:50 PM
Phillips GeraintSVP, Global OperationsAug 25 '23Sale10.991791,96758,045Aug 29 05:49 PM
Rice MichaelChief Executive OfficerAug 14 '23Sale12.382773,429418,635Aug 16 04:49 PM
Mathew Aby J.EVP & Chief Scientific OfficerAug 14 '23Sale12.381802,228271,739Aug 16 04:48 PM
Foster Karen A.Chief Quality OfficerAug 14 '23Sale12.381561,931124,752Aug 16 04:46 PM
Berard ToddChief Marketing OfficerAug 14 '23Sale12.381341,659118,825Aug 16 04:48 PM
Phillips GeraintSVP, Global OperationsAug 14 '23Sale12.571091,37058,224Aug 16 04:47 PM
Schulz MarcusChief Revenue OfficerAug 14 '23Sale12.381081,33742,444Aug 16 04:49 PM
Aebersold SarahChief Human Resources OfficerAug 14 '23Sale12.381041,28843,879Aug 16 04:46 PM
Wichterman TroyChief Financial OfficerAug 14 '23Sale12.57941,18266,518Aug 16 04:47 PM
Casdin Partners Master Fund, L10% OwnerAug 09 '23Buy13.2058,465771,7447,630,000Aug 11 05:01 PM
Schulz MarcusChief Revenue OfficerJul 24 '23Sale19.5067913,24042,552Jul 26 06:09 PM
Aebersold SarahChief Human Resources OfficerJul 24 '23Sale19.504629,00943,983Jul 26 06:08 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 20 '23Option Exercise2.0610,00020,600281,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 20 '23Sale20.0710,000200,700271,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 19 '23Option Exercise2.0610,00020,600281,919Jul 24 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJul 19 '23Sale20.4610,000204,600271,919Jul 24 04:35 PM
Schulz MarcusChief Revenue OfficerJul 11 '23Sale22.793317,54343,231Jul 13 05:10 PM
Rice MichaelChief Executive OfficerJun 27 '23Sale22.9187720,092418,912Jun 29 04:40 PM
Mathew Aby J.EVP & Chief Scientific OfficerJun 27 '23Sale22.9169515,922271,919Jun 29 04:38 PM
Foster Karen A.Chief Quality OfficerJun 27 '23Sale22.9159013,517124,908Jun 29 04:37 PM
Berard ToddChief Marketing OfficerJun 27 '23Sale22.9148911,203118,959Jun 29 04:35 PM
Mathew Aby J.EVP & Chief Scientific OfficerJun 22 '23Option Exercise2.0610,00020,600282,614Jun 23 04:58 PM
Mathew Aby J.EVP & Chief Scientific OfficerJun 22 '23Sale23.3210,000233,200272,614Jun 23 04:58 PM
Wichterman TroyChief Financial OfficerJun 22 '23Sale23.4154112,66566,612Jun 26 04:36 PM
Mathew Aby J.EVP & Chief Scientific OfficerJun 21 '23Option Exercise2.0610,00020,600282,614Jun 23 04:58 PM
Mathew Aby J.EVP & Chief Scientific OfficerJun 21 '23Sale22.9710,000229,700272,614Jun 23 04:58 PM
Rice MichaelCEOMay 31 '23Sale23.211,67938,970419,789Jun 02 08:00 PM
Wichterman TroyChief Financial OfficerMay 31 '23Sale23.2156012,99867,153Jun 02 08:01 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 31 '23Sale23.2150411,698272,614Jun 02 08:02 PM
Foster Karen A.Chief Quality OfficerMay 31 '23Sale23.213929,098125,498Jun 02 08:00 PM
Schulz MarcusChief Revenue OfficerMay 31 '23Sale23.213377,82243,562Jun 02 08:01 PM
Berard ToddChief Marketing OfficerMay 31 '23Sale23.213377,822119,448Jun 02 08:01 PM
Aebersold SarahChief Human Resources OfficerMay 31 '23Sale23.213377,82244,445Jun 02 08:00 PM
Phillips GeraintSVP, Global OperationsMay 31 '23Sale23.211744,03958,333Jun 23 07:30 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 25 '23Option Exercise2.0610,00020,600283,118May 25 08:18 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 25 '23Sale22.3310,000223,300273,118May 25 08:18 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 24 '23Option Exercise2.0610,00020,600283,118May 25 08:18 PM
Mathew Aby J.EVP & Chief Scientific OfficerMay 24 '23Sale22.1410,000221,400273,118May 25 08:18 PM
Casdin Partners Master Fund, L10% OwnerMay 22 '23Buy21.8624,973545,790150,000May 23 05:46 PM
Casdin Partners Master Fund, L10% OwnerMay 19 '23Buy22.5550,0001,127,430125,027May 23 05:46 PM